|
1
|
Collison J: Osteoporosis: Teriparatide
preferable for fracture prevention. Nat Rev Rheumatol. 14:42018.
View Article : Google Scholar
|
|
2
|
Chrischilles EA, Butler CD, Davis CS and
Wallace RB: A model of lifetime osteoporosis impact. Arch Intern
Med. 151:2026–2032. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pepe J, Cipriani C, Cecchetti V, et al:
Patients' reasons for adhering to long-term alendronate therapy.
Osteoporosis international. 2019 May 14;[Epub ahead of print] doi:
10.1007/s00198-019-05010-w. View Article : Google Scholar
|
|
4
|
Wang C, Wang J, Li J, Hu G, Shan S, Li Q
and Zhang X: KDM5A controls bone morphogenic protein 2-induced
osteogenic differentiation of bone mesenchymal stem cells during
osteoporosis. Cell Death Dis. 7:e23352016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Elango J, Robinson J, Zhang J, Bao B, Ma
N, de Val JEMS and Wu W: Collagen peptide upregulates
osteoblastogenesis from bone marrow mesenchymal stem cells through
MAPK-Runx2. Cells. 8:2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qi M, Zhang L, Ma Y, Shuai Y, Li L, Luo K,
Liu W and Jin Y: Autophagy maintains the function of bone marrow
mesenchymal stem cells to prevent estrogen deficiency-induced
osteoporosis. Theranostics. 7:4498–4516. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jing H, Liao L, An Y, Su X, Liu S, Shuai
Y, Zhang X and Jin Y: Suppression of EZH2 prevents the shift of
osteoporotic MSC fate to adipocyte and enhances bone formation
during osteoporosis. Mol Ther. 24:217–229. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
An J, Yang H, Zhang Q, Liu C, Zhao J,
Zhang L and Chen B: Natural products for treatment of osteoporosis:
The effects and mechanisms on promoting osteoblast-mediated bone
formation. Life Sci. 147:46–58. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang DZ, Yang F, Yang Z, Huang J, Shi Q,
Chen D and Wang YJ: Psoralen stimulates osteoblast differentiation
through activation of BMP signaling. Biochem Biophys Res Commun.
405:256–261. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Czech MP: MicroRNAs as therapeutic
targets. N Engl J Med. 354:1194–1195. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Laxman N, Mallmin H, Nilsson O and
Kindmark A: miR-203 and miR-320 regulate bone morphogenetic
protein-2-induced osteoblast differentiation by targeting
distal-less homeobox 5 (Dlx5). Genes (Basel). 8:2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chao C, Li F, Tan Z, Zhang W, Yang Y and
Luo C: miR-195 inhibited abnormal activation of osteoblast
differentiation in MC3T3-E1 cells via targeting RAF-1. Exp Cell
Res. 362:293–301. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tian Z, Zhou H, Xu Y and Bai J:
MicroRNA-495 inhibits new bone regeneration via targeting high
mobility group AT-Hook 2 (HMGA2). Med Sci Monit. 23:4689–4698.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Almalki SG and Agrawal DK: Key
transcription factors in the differentiation of mesenchymal stem
cells. Differentiation. 92:41–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stephens AS and Morrison NA: Novel target
genes of RUNX2 transcription factor and 1,25-dihydroxyvitamin D3. J
Cell Biochem. 115:1594–1608. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meister G: Argonaute proteins: Functional
insights and emerging roles. Nat Rev Genet. 14:447–459. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu D, Shen D, Zhang M, Jiang N, Sun F,
Yuan S and Wan K: MiR-488 suppresses cell proliferation and
invasion by targeting ADAM9 and lncRNA HULC in hepatocellular
carcinoma. Am J Cancer Res. 7:2070–2080. 2017.PubMed/NCBI
|
|
19
|
Yang Z, Feng Z, Gu J, Li X, Dong Q, Liu K,
Li Y and OuYang L: microRNA-488 inhibits chemoresistance of ovarian
cancer cells by targeting Six1 and mitochondrial function.
Oncotarget. 8:80981–80993. 2017.PubMed/NCBI
|
|
20
|
Lv Y, Shi Y, Han Q and Dai G: Histone
demethylase PHF8 accelerates the progression of colorectal cancer
and can be regulated by miR-488 in vitro. Mol Med Rep.
16:4437–4444. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu S, Geng Q, Pan Q, Liu Z, Ding S, Xiang
Q, Sun F, Wang C, Huang Y and Hong A: MiR-690, a Runx2-targeted
miRNA, regulates osteogenic differentiation of C2C12 myogenic
progenitor cells by targeting NF-kappaB p65. Cell Biosci. 6:102016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu S, Geng Q, Ma J, Sun F, Yu Y, Pan Q and
Hong A: Heparin-binding EGF-like growth factor and miR-1192 exert
opposite effect on Runx2-induced osteogenic differentiation. Cell
Death Dis. 4:e8682013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Z, Wang W, Xu H, Ning Y, Fang W, Liao
W, Zou J, Yang Y and Shao N: Effects of altered CXCL12/CXCR4 axis
on BMP2/Smad/Runx2/Osterix axis and osteogenic gene expressions
during osteogenic differentiation of MSCs. Am J Transl Res.
9:1680–1693. 2017.PubMed/NCBI
|
|
24
|
Kim HK, Cho SG, Kim JH, Doan TK, Hu QS,
Ulhaq R, Song EK and Yoon TR: Mevinolin enhances osteogenic genes
(ALP, type I collagen and osteocalcin), CD44, CD47 and CD51
expression during osteogenic differentiation. Life Sci. 84:290–295.
2009. View Article : Google Scholar : PubMed/NCBI
|
